The Pseudomonas aeruginosa Type III Translocon Is Required for Biofilm Formation at the Epithelial Barrier

PLoS Pathogens

Volumn 10, Issue 11, 2014, Pages

  Tran, Cindy S ^a   Rangel, Stephanie M ^b   Almblad, Henrik ^c   Kierbel, Arlinet ^d   Givskov, Michael ^c,e   Tolker Nielsen, Tim ^c   Hauser, Alan R ^b   Engel, Joanne N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSLOCON; BACTERIAL SECRETION SYSTEM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIOFILM; CELL AGGREGATION; CELL PERMEABILIZATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; TYPE III SECRETION SYSTEM; ANIMAL; BACTERIAL PNEUMONIA; BACTERIAL SECRETION SYSTEM; DISEASE MODEL; DOG; GENETICS; IMMUNOLOGY; MDCK CELL LINE; MICROBIOLOGY; MUTATION; PATHOLOGY; PHYSIOLOGY; PSEUDOMONAS INFECTION;

PSEUDOMONAS AERUGINOSA;

ANIMALS; BACTERIAL SECRETION SYSTEMS; BIOFILMS; DISEASE MODELS, ANIMAL; DOGS; EPITHELIAL CELLS; MADIN DARBY CANINE KIDNEY CELLS; MICE; MUTATION; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84912129701     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004479     Document Type: Article

References (59)

1. Costerton JW, Stewart PS, Greenberg EP, (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318–1322.
2. Hall-Stoodley L, Stoodley P, Kathju S, Hoiby N, Moser C, et al. (2012) Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol 65: 127–145.
3. Parsek MR, Singh PK, (2003) Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57: 677–701.
4. Hall-Stoodley L, Costerton JW, Stoodley P, (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nature reviews Microbiology 2: 95–108.
5. Furukawa S, Kuchma SL, O'Toole GA, (2006) Keeping their options open: acute versus persistent infections. Journal of bacteriology 188: 1211–1217.
6. Goodman AL, Kulasekara B, Rietsch A, Boyd D, Smith RS, et al. (2004) A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev Cell 7: 745–754.
7. Horsman SR, Moore RA, Lewenza S, (2012) Calcium chelation by alginate activates the type III secretion system in mucoid Pseudomonas aeruginosa biofilms. PLoS One 7: e46826.
8. Manos J, Arthur J, Rose B, Bell S, Tingpej P, et al. (2009) Gene expression characteristics of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa during biofilm and planktonic growth. FEMS Microbiol Lett 292: 107–114.
9. Mikkelsen H, Bond NJ, Skindersoe ME, Givskov M, Lilley KS, et al. (2009) Biofilms and type III secretion are not mutually exclusive in Pseudomonas aeruginosa. Microbiology 155: 687–698.
10. Moreau-Marquis S, Bomberger JM, Anderson GG, Swiatecka-Urban A, Ye S, et al. (2008) The {Delta}F508-CFTR Mutation Results in Increased Biofilm Formation by P. aeruginosa by Increasing Iron Availability. Am J Physiol Lung Cell Mol Physiol 295: L25–37.
11. Woodworth BA, Tamashiro E, Bhargave G, Cohen NA, Palmer JN, (2008) An in vitro model of Pseudomonas aeruginosa biofilms on viable airway epithelial cell monolayers. Am J Rhinol 22: 235–238.
12. Bucior I, Mostov K, Engel JN, (2010) Pseudomonas aeruginosa-mediated damage requires distinct receptors at the apical and basolateral surfaces of the polarized epithelium. Infect Immun 78: 939–953.
13. Bucior I, Pielage JF, Engel JN, (2012) Pseudomonas aeruginosa pili and flagella mediate distinct binding and signaling events at the apical and basolateral surface of airway epithelium. PLoS pathogens 8: e1002616.
14. Mostov KE, (1995) Regulation of protein traffic in polarized epithelial cells. Histol Histopathol 10: 423–431.
15. Kierbel A, Gassama-Diagne A, Rocha C, Radoshevich L, Olson J, et al. (2007) Pseudomonas aeruginosa exploits a PIP3-dependent pathway to transform apical into basolateral membrane. J Cell Biol 177: 21–27.
16. Lepanto P, Bryant DM, Rossello J, Datta A, Mostov KE, et al. (2011) Pseudomonas aeruginosa interacts with epithelial cells rapidly forming aggregates that are internalized by a Lyn-dependent mechanism. Cellular microbiology 13: 1212–1222.
17. Tran C, Eran Y, Ruch T, Bryant D, Datta A, et al. (2014) Host cell polarity proteins participate in innate immunity to Pseudomonas aeruginosa infection. Cell Host Microbe in press.
18. O'Toole GA, Kolter R, (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30: 295–304.
19. Allesen-Holm M, Barken KB, Yang L, Klausen M, Webb JS, et al. (2006) A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 59: 1114–1128.
20. Ma L, Conover M, Lu H, Parsek MR, Bayles K, et al. (2009) Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 5: e1000354.
21. Ma L, Lu H, Sprinkle A, Parsek MR, Wozniak DJ, (2007) Pseudomonas aeruginosa Psl is a galactose- and mannose-rich exopolysaccharide. J Bacteriol 189: 8353–8356.
22. Klausen M, Heydorn A, Ragas P, Lambertsen L, Aaes-Jorgensen A, et al. (2003) Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol 48: 1511–1524.
23. Engel J, Balachandran P, (2009) Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol 12: 61–66.
24. Kuchma SL, Connolly JP, O'Toole GA, (2005) A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa. J Bacteriol 187: 1441–1454.
25. Ventre I, Goodman AL, Vallet-Gely I, Vasseur P, Soscia C, et al. (2006) Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. Proc Natl Acad Sci U S A 103: 171–176.
26. Watton SJ, Downward J, (1999) Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction. Curr Biol 9: 433–436.
27. Lee VT, Smith RS, Tummler B, Lory S, (2005) Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection. Infect Immun 73: 1695–1705.
28. Kang PJ, Hauser AR, Apodaca G, Fleiszig SM, Wiener-Kronish J, et al. (1997) Identification of Pseudomonas aeruginosa genes required for epithelial cell injury. Mol Microbiol 24: 1249–1262.
29. Diaz MH, Hauser AR, (2010) Pseudomonas aeruginosa cytotoxin ExoU is injected into phagocytic cells during acute pneumonia. Infect Immun 78: 1447–1456.
30. Sundin C, Wolfgang MC, Lory S, Forsberg A, Frithz-Lindsten E, (2002) Type IV pili are not specifically required for contact dependent translocation of exoenzymes by Pseudomonas aeruginosa. Microb Pathog 33: 265–277.
31. Hauser AR, (2009) The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 7: 654–665.
32. Bhakdi S, Bayley H, Valeva A, Walev I, Walker B, et al. (1996) Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch Microbiol 165: 73–79.
33. Moreau-Marquis S, O'Toole GA, Stanton BA, (2009) Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am J Respir Cell Mol Biol 41: 305–313.
34. Dacheux D, Goure J, Chabert J, Usson Y, Attree I, (2001) Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages. Mol Microbiol 40: 76–85.
35. Goure J, Pastor A, Faudry E, Chabert J, Dessen A, et al. (2004) The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes. Infect Immun 72: 4741–4750.
36. Vance RE, Rietsch A, Mekalanos JJ, (2005) Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect Immun 73: 1706–1713.
37. Galle M, Jin S, Bogaert P, Haegman M, Vandenabeele P, et al. (2012) The Pseudomonas aeruginosa type III secretion system has an exotoxon S/T/Y independent pathogenic role during acute lung infection. PLoS One 7: 1–8.
38. Lavoie EG, Wangdi T, Kazmierczak BI, (2011) Innate immune responses to Pseudomonas aeruginosa infection. Microbes and infection/Institut Pasteur 13: 1133–1145.
39. Schaber JA, Triffo WJ, Suh SJ, Oliver JW, Hastert MC, et al. (2007) Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infection and immunity 75: 3715–3721.
40. Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, et al. (2004) Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A 101: 1333–1338.
41. Alhede M, Kragh KN, Qvortrup K, Allesen-Holm M, van Gennip M, et al. (2011) Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. PLoS One 6: e27943.
42. Staudinger BJ, Muller JF, Halldorsson S, Boles B, Angermeyer A, et al. (2014) Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 189: 812–824.
43. Colvin KM, Gordon VD, Murakami K, Borlee BR, Wozniak DJ, et al. (2011) The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa. PLoS pathogens 7: e1001264.
44. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103: 8487–8492.
45. Jain M, Bar-Meir M, McColley S, Cullina J, Potter E, et al. (2008) Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infection. Transl Res 152: 257–264.
46. Hu H, Harmer C, Anuj S, Wainwright CE, Manos J, et al. (2012) Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening. Clin Microbiol Infect 19 doi:10.1111/j.1469-0691.2012.03770.x
47. Nguyen D, Singh PK, (2006) Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc Natl Acad Sci U S A 103: 8305–8306.
48. Yu W, O'Brien LE, Wang F, Bourne H, Mostov KE, et al. (2003) Hepatocyte growth factor switches orientation of polarity and mode of movement during morphogenesis of multicellular epithelial structures. Mol Biol Cell 14: 748–763.
49. Kierbel A, Gassama-Diagne A, Mostov K, Engel JN, (2005) The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization. Mol Biol Cell 16: 2577–2585.
50. Kazmierczak BI, Jou TS, Mostov K, Engel JN, (2001) Rho GTPase activity modulates Pseudomonas aeruginosa internalization by epithelial cells. Cell Microbiol 3: 85–98.
51. Apodaca G, Katz LA, Mostov KE, (1994) Receptor-mediated transcytosis of IgA in MDCK cells is via apical recycling endosomes. Journal of Cell Biology 125: 67–86.
52. Edelstein A, Amodaj N, Hoover K, Vale R, Stuurman N, (2010) Computer control of microscopes using microManager. Current protocols in molecular biology/edited by Frederick M Ausubel doi:10.1002/0471142727.mb1420s92
53. Schneider CA, Rasband WS, Eliceiri KW, (2012) NIH Image to ImageJ: 25 years of image analysis. Nature methods 9: 671–675.
54. Bolte S, Cordelieres FP, (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224: 213–232.
55. Comolli JC, Hauser AR, Waite L, Whitchurch CB, Mattick JS, et al. (1999) Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia. Infect Immun 67: 3625–3630.
56. O'Toole GA, (2011) Microtiter dish biofilm formation assay. J Vis Exp 47 doi:10.3791/2437
57. Dasgupta N, Wolfgang MC, Goodman AL, Arora SK, Jyot J, et al. (2003) A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol Microbiol 50: 809–824.
58. Watson AA, Mattick JS, Alm RA, (1996) Functional expression of heterologous type 4 fimbriae in Pseudomonas aeruginosa. Gene 175: 143–150.
59. Brannon MK, Davis JM, Mathias JR, Hall CJ, Emerson JC, et al. (2009) Pseudomonas aeruginosa Type III secretion system interacts with phagocytes to modulate systemic infection of zebrafish embryos. Cellular microbiology 11: 755–768.